文献速递乳腺癌

单核苷酸多态性与乳腺X线密度联合经典因素用于乳腺癌风险预测

Use of Single-Nucleotide Polymorphisms and Mammographic Density Plus Classic Risk Factors for Breast Cancer Risk Prediction.
PubMed 文献 · JAMA Oncol · 2018-01-01

这项队列研究纳入9363名46-73岁无乳腺癌史女性,评估18个SNP(SNP18)联合Tyrer-Cuzick模型和乳腺X线密度预测乳腺癌的能力。SNP18在未调整和调整后均与乳腺癌风险相关(OR每四分位距1.56和1.53),联合风险评估可将18%亚队列归为10年风险≥5%,该组涵盖30%的全部乳腺癌、35%的间期癌和42%的2期以上癌。

要点

  • SNP18联合经典因素和乳腺密度可提升乳腺癌风险分层。
  • 联合评估将18%女性归为10年风险≥5%,涵盖42%的2期以上癌。
  • 33%女性10年风险<2%,仅占全部乳腺癌的18%。

核心结论

  • SNP18为基于Tyrer-Cuzick模型和乳腺密度的风险评估提供了大量额外信息,联合风险可能有助于风险分层筛查和预防策略。

研究设计与样本

  • 前瞻性队列研究PROCAS的子队列,纳入9363名46-73岁无既往乳腺癌诊断的女性。
  • 2009年10月至2015年6月从英格兰大曼彻斯特多个人群筛查中心入组,随访至2017年1月5日。

主要发现

  • 9363名女性中位年龄59岁(范围46-73),共466例乳腺癌(271例 prevalent,195例 incident)。
  • SNP18未调整和调整乳腺密度及经典因素后预测能力相似,OR每四分位距分别为1.56(95%CI 1.38-1.77)和1.53(95%CI 1.35-1.74)。
  • 调整后观察与预期比值比为0.98(95%CI 0.69-1.28)。
  • 联合风险评估显示18%亚队列10年风险≥5%,对应30%全部乳腺癌、35%间期癌和42%的2期以上癌。
  • 33%亚队列10年风险<2%,仅对应18%全部乳腺癌、17%间期癌和15%的2期以上癌。

关键数值与推荐

  • SNP18每四分位距预测乳腺癌的未调整OR为1.56(95%CI 1.38-1.77)。
  • 调整乳腺密度和经典因素后OR为1.53(95%CI 1.35-1.74)。
  • 调整后观察与预期比值比为0.98(95%CI 0.69-1.28)。
  • 联合风险评估将18%亚队列归为10年风险≥5%,33%归为<2%。

临床怎么用

  • 可将18个SNP联合Tyrer-Cuzick模型和乳腺X线密度用于乳腺癌风险分层。
  • 联合风险评估有助于识别10年风险≥5%的女性,可能指导筛查和预防策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Single-nucleotide polymorphisms (SNPs) have demonstrated an association with breast cancer susceptibility, but there is limited evidence on how to incorporate them into current breast cancer risk prediction models. OBJECTIVE: To determine whether a panel of 18 SNPs (SNP18) may be used to predict breast cancer in combination with classic risk factors and mammographic density. DESIGN, SETTING, AND PARTICIPANTS: This cohort study enrolled a subcohort of 9363 women, aged 46 to 73 years, without a previous breast cancer diagnosis from the larger prospective cohort of the PROCAS study (Predicting Risk of Cancer at Screening) specifically to evaluate breast cancer risk-assessment methods. Enrollment took place from October 2009 through June 2015 from multiple population-based screening centers in Greater Manchester, England. Follow-up continued through January 5, 2017. EXPOSURES: Genotyping of 18 SNPs, visual-assessment percentage mammographic density, and classic risk assessed by the Tyrer-Cuzick risk model from a self-completed questionnaire at cohort entry. MAIN OUTCOMES AND MEASURES: The predictive ability of SNP18 for breast cancer diagnosis (invasive and ductal carcinoma in situ) was assessed using logistic regression odds ratios per interquartile range of the predicted risk. RESULTS: A total of 9363 women were enrolled in this study (mean [range] age, 59 [46-73] years). Of these, 466 were found to have breast cancer (271 prevalent; 195 incident). SNP18 was similarly predictive when unadjusted or adjusted for mammographic density and classic factors (odds ratios per interquartile range, respectively, 1.56; 95% CI, 1.38-1.77 and 1.53; 95% CI, 1.35-1.74), with observed risks being very close to expected (adjusted observed-to-expected odds ratio, 0.98; 95% CI, 0.69-1.28). A combined risk assessment indicated 18% of the subcohort to be at 5% or greater 10-year risk, compared with 30% of all cancers, 35% of interval-detected cancers, and 42% of stage 2+ cancers. In contrast, 33% of the subcohort were at less than 2% risk but accounted for only 18%, 17%, and 15% of the total, interval, and stage 2+ breast cancers, respectively. CONCLUSIONS AND RELEVANCE: SNP18 added substantial information to risk assessment based on the Tyrer-Cuzick model and mammographic density. A combined risk is likely to aid risk-stratified screening and prevention strategies.

来源:JAMA Oncol,查看原文。版权归原作者所有。

引用

  1. van Veen EM, Brentnall AR, Byers H, et al. Use of Single-Nucleotide Polymorphisms and Mammographic Density Plus Classic Risk Factors for Breast Cancer Risk Prediction. JAMA Oncol. 2018. PMID: 29346471. doi:10.1001/jamaoncol.2017.4881

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。